Illumina ILMN
NASDAQ ILMN
$245.18 +16.25 (+7.10%)
At close: Sep 17, 2026 · 4:00 PM EDT

Illumina (ILMN) Other Non-Current Liabilities (2010 - 2026)

Illumina's (ILMN) quarterly Other Non-Current Liabilities came in at $289.0 million in Q2 2026, down 16.95% on a YoY basis from $348.0 million in Q2 2025, and down 17.9% quarter-over-quarter from $352.0 million in Q1 2026.

Analysis

Illumina (ILMN) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends

Illumina (ILMN) has reported Other Non-Current Liabilities for 17 consecutive years, with $289.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Other Non-Current Liabilities fell 16.95% year-over-year to $289.0 million; the trailing twelve-month figure through Jun 2026 stood at $289.0 million (down 16.95% YoY), and the FY2025 full-year result was $360.0 million, up 6.19% from the prior year.
  • Other Non-Current Liabilities eased to $289.0 million in Q2 2026 per ILMN's latest filing, from $352.0 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $915.0 million in Q1 2022 and bottomed at $289.0 million in Q2 2026.
  • Historically, Other Non-Current Liabilities has averaged $529.4 million across 5 years, with a median of $555.0 million in 2023.
  • The sharpest annual moves came in 2022 and 2024: Other Non-Current Liabilities jumped 269.0% in 2022, then tumbled 52.85% in 2024.
  • Over 5 years, Other Non-Current Liabilities stood at $613.0 million in 2022, then climbed by 1.14% to $620.0 million in 2023, then plunged by 45.32% to $339.0 million in 2024, then gained by 6.19% to $360.0 million in 2025, then retreated by 19.72% to $289.0 million in 2026.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $289.0 million, $352.0 million, and $360.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 289.00 Mn
Mar 29, 2026 352.00 Mn
Dec 28, 2025 360.00 Mn
Sep 28, 2025 334.00 Mn
Jun 29, 2025 348.00 Mn
Mar 30, 2025 344.00 Mn
Dec 29, 2024 339.00 Mn
Sep 29, 2024 313.00 Mn
Jun 30, 2024 331.00 Mn
Mar 31, 2024 642.00 Mn
Dec 31, 2023 620.00 Mn
Oct 1, 2023 555.00 Mn
Jul 2, 2023 702.00 Mn
Apr 2, 2023 654.00 Mn
Jan 1, 2023 649.00 Mn
Oct 2, 2022 613.00 Mn
Jul 3, 2022 853.00 Mn
Apr 3, 2022 845.00 Mn
Jan 2, 2022 915.00 Mn
Oct 3, 2021 1.09 Bn